EXPERT VIEW

EXPERT VIEW

ON-BODY DELIVERY SYSTEMS – NEWS AND TRENDS

Tom Oakley discusses the current state of play in the on-body delivery system space, reviews recent milestones and proposes directions for the future.

EXPERT VIEW

KEY CONSIDERATIONS WHEN SPECIFYING A MOTION SYSTEM FOR WEARABLE INJECTORS

The reliable performance of a wearable drug delivery device is understandably paramount, so optimising the motion solution that drives it is crucial. Dave Beckstoffer discusses how best to achieve this and ensure the best match between the motion solution and the characteristics of the specified drug or drug range.

EXPERT VIEW

Sara Dorman

IMPROVE YOUR BIOPHARMACEUTICAL WORKFLOW: 6 BENEFITS OF SINGLE-USE SYSTEM TECHNOLOGIES

Sara Dorman discusses the benefits of single-use systems, including how they help accelerate a drug product’s journey to market securely and more sustainably.

EXPERT VIEW

Jeff Lowe

SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING

 Jeff Lowe considers single-use systems and looks at their role in the future of biopharmaceutical processing.

EXPERT VIEW

Dr Yongdong Zhou

DISSECTING THE DELICATE DELIVERY PROCESS FOR OCULAR GENE THERAPY

Yongdong Zhou considers the challenges of ocular gene therapy delivery approaches.

EXPERT VIEW

Rina Chokshi

FORMULATING SUPERIOR ORAL SUSPENSIONS FOR BETTER PATIENT COMPLIANCE

Rina Chokshi and Dago Caceres discuss how leveraging key ingredients in oral suspensions can enhance stability and sensory attributes, as well as encourage patient compliance.

EXPERT VIEW

Dr Bernard Vrijens

FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS

Bernard Vrijens looks at the effect of decentralised clinical trials on medication adherence in clinical studies.

EXPERT VIEW

Dr Ben Cox

HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES

Ben Cox discusses the key challenges, principles and advantages of following a user-experience approach to digital health technologies in clinical trials.

EXPERT VIEW

Sylvia Kaiser

HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE

Sylvia Kaiser-Kershaw discusses how recent near-field communication tagging advancements can enable pharmaceutical companies to protect the authenticity and integrity of their products, while also making it easier for healthcare professionals and patients to use medications more effectively through intelligent drug delivery systems.

EXPERT VIEW

Gabrielle Whitworth-Smith

CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY

Gabrielle Whitworth-Smith and Thomas Watts look at the benefits and risks associated with cloud connectivity and the accompanying cybersecurity challenges.

EXPERT VIEW

Napoleon Monroe

CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND

Napoleon Monroe looks back at the factors that influenced the underwhelming uptake of connectivity-enabling technologies in the healthcare sector over the first two decades of the 21st century, how the covid-19 pandemic changed everything and what current healthcare challenges connectivity might solve.

EXPERT VIEW

Paul Edalat

SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW

Paul Edalat and Mehdi Hatamian take an in-depth look at medication non-adherence and how technology can be used to improve compliance rates and optimise patient outcomes.

EXPERT VIEW

Dr Anna Cifuentes-Rius

EXTRACELLULAR VESICLE ENGINEERING: OPTIMISING NATURE’S NON-IMMUNOGENIC, DRUG DELIVERY PLATFORM

Anna Cifuentes-Rius discusses the exciting potential of extracellular vesicles to advance drug delivery, in particular their natural ability to carry API payloads across difficult-to-traverse biological barriers.

EXPERT VIEW

Dr Martin Gonzalez

RECENT TRENDS & DEVELOPMENTS IN INJECTABLE FORMULATION & DELIVERY

Martin Gonzalez details current trends in sterile injectable formulations and their delivery devices, and the challenges pharma and its contract development and manufacturing company partners face in bringing emerging breakthroughs to market.

EXPERT VIEW

Rob Udale

ARE GOVERNMENTS BANNING THE MOST ENVIRONMENTALLY FRIENDLY INHALER?

Rob Udale, Catriona Eldridge and Omar Shah assess the assertion that pMDIs are the most environmentally damaging of the available pulmonary drug delivery device archetypes, and explore some of the intricacies not accounted for in the public discourse surrounding pMDIs.

EXPERT VIEW

Dr Jnanadeva Bhat

CAPSULES: CLASSIC DRUG DELIVERY FORM HOLDS POTENTIAL FOR SUSTAINABLE DELIVERY

Jnanadeva Bhat and Anita Solanki discuss the role that hard capsules are able to play in delivering a more sustainable pharmaceutical industry, both as an oral solid dosage form and in dry powder inhalers.

EXPERT VIEW

Frédérique Bordes-Picard

NANOTECHNOLOGY: A NEXT-GENERATION TOOL FOR PULMONARY & NASAL DELIVERY

Frédérique Bordes-Picard looks at the role of nanotechnology in the nasal and pulmonary routes of drug delivery and explains how nanoparticle explains how nanoparticle solutions could transform patient comfort and compliance.

EXPERT VIEW

Rob Udale

WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022

Rob Udale and Heather Jameson discuss the exciting developments taking place in the design of inhalation devices and share their predictions for the top five inhalation trends to watch as 2022 unfolds, and beyond.

EXPERT VIEW

Wilbur de Kruijf

DO SOFT MIST INHALERS HOLD THE KEY TO FASTER INHALATION DRUG DEVELOPMENT?

Wilbur de Kruijf and Bernhard Müllinger discuss the the market requirements for new inhalation options and the benefits of soft mist inhalers.

EXPERT VIEW

Dr Justin Lacombe

USING QUALITY BY DESIGN TO OPTIMISE THE COMBINATION PRODUCT JOURNEY

Justin Lacombe and Julie D Suman explain how applying quality by design principles to combination products improves development efficiency, aligns with design controls, and maximises product safety and efficacy.

EXPERT VIEW

Dr Caterina Minelli

AN INVITATION TO PARTICIPATE IN STANDARDISATION OF PARTICLE MEASUREMENTS FOR PHARMACEUTICALS

Caterina Minelli discusses the importance of co-operation between metrology institutes and the pharmaceutical industry in the pursuit of improving analytical techniques and standards for the characterisation of particle attributes in drug development.

EXPERT VIEW

Daniel Lock

EVOLUTION OF NEBULISATION FOR DRUG DELIVERY TO THE LUNGS

Daniel Lock discusses the latest innovations in nebuliser technology for drug delivery to the lungs.

EXPERT VIEW

Anita Solanki

CAPSULES FOR DRY POWDER INHALATION – A COMPLETE PRODUCT

Anita Solanki, Jnanadeva Bhat and Justin Kalafat discuss capsules for dry powder formulation and consider their potential as a dosage form for patients with respiratory conditions and systemic illnesses.

EXPERT VIEW

Dr Yongdong Zhou

WHY GENE THERAPY IS PERFECT FOR TREATING OCULAR DISEASES

Yongdong Zhou discusses the applications, advantages and challenges of gene therapy in the ophthalmic sector.

EXPERT VIEW

Dr Jay S Duker

ENVISIONING NEW HORIZONS IN OCULAR DRUG DELIVERY

Jay S Duker discusses the history and future of ocular drug delivery, with a special focus on posterior segment diseases and the battle to overcome significant patient and caregiver burdens.

EXPERT VIEW

Robert Lee

KEEPING UP WITH THE DEMAND FOR EFFECTIVE OPHTHALMIC DRUGS

Robert Lee explores the growth of the ophthalmic drug market and discuss the challenges that pharma companies may face when creating drugs to treat some of the most common ocular indications.

EXPERT VIEW

Michael Neely

A VIEW ON THE USE OF APROTIC SOLVENTS IN PARENTERAL DRUG FORMULATIONS

Michael Neely presents a review and discussion of the status of aprotic solvents as a solubilising vehicle for parenteral drug formulations in the context of the industry’s increasing interest in biologic drugs.

EXPERT VIEW

Tom Oakley

DRUG DELIVERY DEVICE TRENDS FOR 2022

Tom Oakley looks at some of the current trends in the drug delivery industry and projects some of the key factors that will influence drug delivery decision making in 2022.

EXPERT VIEW

Salvatore Forte

VOICE-ACTIVATED USER INTERFACES IN DRUG DELIVERY DEVICES CAN ENHANCE COMPLIANCE AND OUTCOMES

Salvatore Forte looks at the evolution of voice-activated interfaces in medical devices, particularly autoinjectors, and the advantages for patient compliance and quality of care.

EXPERT VIEW

Dr Celeste Maksim

MDR COMPLIANCE: PLANNING FOR POST-MARKET CLINICAL FOLLOW-UP

Celeste Maksim discusses best practices for drug delivery device manufacturers when conducting post-market clinical follow-up activities, as mandated by the EU Medical Device Regulation.

EXPERT VIEW

Eliza Lee

EVOLVING ANALYTICAL METHODS: ADVANCES IN MOLECULE CHARACTERISATION

Eliza Lee discusses some of the modern analytical techniques available for the characterisation of modern biologics, and how CDMOs equipped with these techniques are able to support pharmaceutical development.

EXPERT VIEW

Natalie Shortt

“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE

Natalie Shortt discusses the considerations and steps to take when planning usability engineering efforts for software as a medical device.

EXPERT VIEW

Robert Lee

ADDRESSING THE CHALLENGES OF NASAL BIOTHERAPEUTIC DRUG DELIVERY

Robert Lee discusses the benefits of administering drugs to the nasal cavity, as well as the main challenges in formulation for this route and the strategies that can be applied to overcome them.

EXPERT VIEW

Jamie Clayton

POWDER CHARACTERISATION: A CRITICAL TOOL FOR THE EVOLUTION OF INHALED DRUG DELIVERY

Jamie Clayton, Joana Pinto and Sarah Zellnitz discuss the benefits of multi-faceted powder characterisation in dry powder inhalation formulations and how it can support efforts to achieve net zero emissions.

EXPERT VIEW

Cormac O'Prey

SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR

Cormac O’Prey discusses some of the sustainability challenges facing the medical sector, such as how to make re-use and remanufacturing viable for high-volume, low-value products, and how answers can be found by looking to successful solutions deployed by other industries.

EXPERT VIEW

PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021

Pharmapack presents the results of its annual survey and market report, covering the latest Pharmapack Innovation Index and the inaugural Pharmapack Sustainability Index, and taking stock of where the survey results suggest the pharma industry currently is, and where it is heading, in terms of innovation and sustainability.

EXPERT VIEW

Charlie Dean

EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY

Charlie Dean, Kay Sinclair and Brennan Miles provide an overview of eight terms key to a common understanding in the ongoing, and crucial, discussion surrounding sustainability.

INTERVIEW

Mathias Romacker

INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT

In this exclusive interview, Mathias Romacker discusses a broad range of topics, from his professional expertise and history seeing the parenteral sector evolve first-hand, to his personal experience as a Crohn’s disease patient making use of the very devices he’s seen grow and develop.